Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy

G Kheiri, M Dolatshahi, F Rahmani… - Reviews in the …, 2018 - degruyter.com
A myriad of environmental and genetic factors, as well as the physiologic process of aging,
contribute to Alzheimer's disease (AD) pathology. Neuroinflammation is and has been a …

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

L Munoz, AJ Ammit - Neuropharmacology, 2010 - Elsevier
Accumulating evidence indicates that p38 mitogen-activated protein kinase (MAPK) could
play more than one role in Alzheimer's disease (AD) pathophysiology and that patients …

Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer's disease

JK Lee, NJ Kim - Molecules, 2017 - mdpi.com
P38 mitogen-activated protein kinase (MAPK) is a crucial target for chronic inflammatory
diseases. Alzheimer's disease (AD) is characterized by the presence of amyloid plaques …

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

X Zhu, H Lee, AK Raina, G Perry, MA Smith - Neurosignals, 2002 - karger.com
Given the critical role of mitogen-activated protein kinase (MAPK) pathways in regulating
cellular processes that are affected in Alzheimer's disease (AD), the importance of MAPKs in …

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's …

L Munoz, HR Ranaivo, SM Roy, W Hu, JM Craft… - Journal of …, 2007 - Springer
Background An accumulating body of evidence is consistent with the hypothesis that
excessive or prolonged increases in proinflammatory cytokine production by activated glia is …

The p38 MAP kinase signaling pathway in Alzheimer's disease

GVW Johnson, CDC Bailey - Experimental neurology, 2003 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia in the elderly. AD is
characterized by progressive neuronal degeneration that is accompanied by the formation of …

Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer's disease: understanding the therapeutics strategies

PK Kamat, A Kalani, S Rai, S Swarnkar, S Tota… - Molecular …, 2016 - Springer
Synapses are formed by interneuronal connections that permit a neuronal cell to pass an
electrical or chemical signal to another cell. This passage usually gets damaged or lost in …

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do, N Kim, YJ Ju… - Alzheimer's research & …, 2020 - Springer
Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …

Selective brain-targeted antagonism of p38 MAPKα reduces hippocampal IL-1β levels and improves morris water maze performance in aged rats

JJ Alam - Journal of Alzheimer's Disease, 2015 - content.iospress.com
Background: P38 mitogen activated protein kinase (MAPK) α modulates microglia-mediated
inflammatory responses and a number of neuronal physiological processes. Objective: To …

Involvement of p38 MAPK in synaptic function and dysfunction

C Falcicchia, F Tozzi, O Arancio, DM Watterson… - International journal of …, 2020 - mdpi.com
Many studies have revealed a central role of p38 MAPK in neuronal plasticity and the
regulation of long-term changes in synaptic efficacy, such as long-term potentiation (LTP) …